C15.5
Conditions
Interventions
Group 1: Patients with distal esophageal cancer or esophagogastric junction cancer (cancer of the cardia) scheduled for esophagectomy will be enrolled in this study. Before surgery, an endoscopy will
Sponsors
Klinik und Poliklinik für Allgemein-, Viszeral- und TumorchirurgieUniklinik Köln
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Patients with clinically advanced stage adenocarcinoma of the esophagus (T2-T4, N0-N3) undergoing surgical resection
Exclusion criteria
Exclusion criteria: Patient refuses intervention
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Patients will undergo laparoscopic mobilization of the stomach and abdominal lymphadenectomy, followed by transthoracic thoracoscopic or open esophagectomy and thoracic lymphadenectomy using fluorescence imaging as a guide for complete lymph node dissection and to preserve the lymphatic channels. Affected nodes as detected by fluorescence imaging will be marked and dissected separately for later histopathological workup. Primary endpoint will be therefore the visualization of lymphatic channels along first and second tier nodes during the surgery. | — |
Secondary
| Measure | Time frame |
|---|---|
| Pattern of lymph nodes metastatic spread of advanced esophageal Cancer along lymphatic channels (proximal to distal from the Tumor or has direct communication with distal nodes or multidirectional resulting skip metastasis). Visualization during surgery. | — |
Countries
Germany
Contacts
Public ContactHans Fuchs
Klinik und Poliklinik für Allgemein-, Viszeral- und TumorchirurgieUniklinik Köln
Outcome results
None listed